TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “ Company” or “PharmaTher”) (CSE: PHRM)(OTCQB: PHRRF), a clinical-stage psychedelics biotech company, is pleased to announce that it has closed its previously announced private placement with institutional investors of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross proceeds…


Previous articlePharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor
Next articleMINDCURE Announces Commencement of Trading on the OTCQX Best Market